Cellular Senescence and Metabolic reprogramming: Unraveling the Intricate Crosstalk in the Immunosuppressive Tumor Microenvironment
Overview
Authors
Affiliations
The intrinsic oncogenic mechanisms and properties of the tumor microenvironment (TME) have been extensively investigated. Primary features of the TME include metabolic reprogramming, hypoxia, chronic inflammation, and tumor immunosuppression. Previous studies suggest that senescence-associated secretory phenotypes that mediate intercellular information exchange play a role in the dynamic evolution of the TME. Specifically, hypoxic adaptation, metabolic dysregulation, and phenotypic shifts in immune cells regulated by cellular senescence synergistically contribute to the development of an immunosuppressive microenvironment and chronic inflammation, thereby promoting the progression of tumor events. This review provides a comprehensive summary of the processes by which cellular senescence regulates the dynamic evolution of the tumor-adapted TME, with focus on the complex mechanisms underlying the relationship between senescence and changes in the biological functions of tumor cells. The available findings suggest that components of the TME collectively contribute to the progression of tumor events. The potential applications and challenges of targeted cellular senescence-based and combination therapies in clinical settings are further discussed within the context of advancing cellular senescence-related research.
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target.
Sias F, Zoroddu S, Migheli R, Bagella L Int J Mol Sci. 2025; 26(5).
PMID: 40076599 PMC: 11900228. DOI: 10.3390/ijms26051973.
NK cells: shielding senescence homeostasis in the decidua during early pregnancy.
Zheng Z, Shi J, Wang L, Li M Semin Immunopathol. 2025; 47(1):22.
PMID: 40067562 DOI: 10.1007/s00281-025-01048-7.
Sun F, Li W, Du R, Liu M, Cheng Y, Ma J Cell Commun Signal. 2025; 23(1):44.
PMID: 39849559 PMC: 11760674. DOI: 10.1186/s12964-025-02047-9.
Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma.
Liao Y, Chen J, Yao H, Zheng T, Tu J, Chen W J Transl Med. 2025; 23(1):103.
PMID: 39844299 PMC: 11752724. DOI: 10.1186/s12967-025-06086-1.
From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications.
Saliev T, Singh P Cells. 2025; 13(24.
PMID: 39768144 PMC: 11674796. DOI: 10.3390/cells13242052.